Reply to "Capturing Synergy Holistically in Psychedelic Clinical Trials"
- PMID: 38087954
- DOI: 10.1002/cpt.3130
Reply to "Capturing Synergy Holistically in Psychedelic Clinical Trials"
Comment on
-
Capturing Synergy Holistically in Psychedelic Clinical Trials: Assessing Processes in Addition to Outcomes.Clin Pharmacol Ther. 2024 Mar;115(3):400. doi: 10.1002/cpt.3129. Epub 2024 Jan 2. Clin Pharmacol Ther. 2024. PMID: 38168006 No abstract available.
References
-
- Ching, T.H.W. & Shnayder, S. Capturing synergy holistically in psychedelic clinical trials: assessing processes in addition to outcomes. Clin. Pharmacol. Ther. 115, 400 (2024).
-
- Dworkin, R.H., McDermott, M.P., Nayak, S.M. & Strain, E.C. Psychedelics and psychotherapy: is the whole greater than the sum of its parts? Clin. Pharmacol. Ther. 114, 1166-1169 (2023).
-
- Zarin, D.A., Goodman, S.N. & Kimmelman, J. Harms from uninformative clinical trials. JAMA 322, 813-814 (2019).
-
- Fleming, T.R. Discerning hype from substance. Ann. Intern. Med. 153, 400-406 (2010).
-
- Munafò, M.R. et al. A manifesto for reproducible science. Nat. Hum. Behav. 1, 1-9 (2017).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
